Abstract

Antimicrobial resistance (AMR) has emerged as one of the most formidable threats to global health security, disproportionately affecting low- and middle-income countries (LMICs) where diagnostic capacity and surveillance systems remain underdeveloped. This study critically examines global epidemiological trends in AMR and evaluates their implications for clinical microbiology laboratories in LMIC contexts. Drawing upon a comprehensive synthesis of peer-reviewed literature, international policy frameworks, and region-specific evidence, the study adopts a multidisciplinary analytical approach integrating epidemiology, health systems strengthening, technological innovation, and global governance perspectives.
The analysis reveals a marked escalation in the prevalence of multidrug-resistant pathogens, significant regional heterogeneity in resistance patterns, and widening surveillance gaps in resource-constrained settings. Globalization, human mobility, and the residual impact of the COVID-19 pandemic have further complicated resistance dynamics by accelerating cross-border transmission and disrupting routine stewardship and laboratory services. The findings underscore that clinical microbiology laboratories constitute the operational nucleus of effective AMR containment, yet they face systemic challenges, including infrastructural instability, limited molecular diagnostic capacity, workforce shortages, and fragmented data integration systems.
The study concludes that sustainable AMR mitigation in LMICs requires targeted investment in laboratory strengthening, harmonized surveillance frameworks, resilient infrastructure, and digital transformation strategies. Strategic alignment between global policy commitments and localized implementation mechanisms is imperative. It is recommended that national action plans prioritize laboratory network expansion, institutionalize quality assurance standards, integrate real-time data analytics into surveillance platforms, and foster international collaboration for capacity building and technology transfer. Strengthening clinical microbiology laboratories is therefore not merely a technical necessity but a strategic imperative for safeguarding therapeutic efficacy and ensuring long-term global health resilience.